Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus.

PubWeight™: 2.28‹?› | Rank: Top 2%

🔗 View Article (PMID 11136446)

Published in Mol Microbiol on January 01, 2001

Authors

C A Pritzlaff1, J C Chang, S P Kuo, G S Tamura, C E Rubens, V Nizet

Author Affiliations

1: Division of Pediatric Infectious Diseases, University of California, San Diego, 9500 Gilman Drive (0672), La Jolla, CA 92093, USA.

Articles citing this

Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A (2002) 5.28

Streptococcus adherence and colonization. Microbiol Mol Biol Rev (2009) 2.83

Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J Bacteriol (2003) 2.38

Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest (2003) 2.14

Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest (2005) 2.07

Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. Proc Natl Acad Sci U S A (2004) 1.95

Role of pore-forming toxins in bacterial infectious diseases. Microbiol Mol Biol Rev (2013) 1.91

Genome engineering in Bacillus anthracis using Cre recombinase. Infect Immun (2006) 1.74

Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease. Infect Immun (2002) 1.52

The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis (2009) 1.52

Regulation of virulence by a two-component system in group B streptococcus. J Bacteriol (2005) 1.46

Regulation of cytotoxin expression by converging eukaryotic-type and two-component signalling mechanisms in Streptococcus agalactiae. Mol Microbiol (2006) 1.39

Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae. Infect Immun (2003) 1.33

A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta. J Exp Med (2013) 1.31

A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence. FASEB J (2008) 1.31

Understanding the regulation of Group B Streptococcal virulence factors. Future Microbiol (2009) 1.27

The putative glycosyltransferase-encoding gene cylJ and the group B Streptococcus (GBS)-specific gene cylK modulate hemolysin production and virulence of GBS. Infect Immun (2007) 1.22

A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins. Protein Expr Purif (2011) 1.21

Streptolysin S inhibits neutrophil recruitment during the early stages of Streptococcus pyogenes infection. Infect Immun (2009) 1.20

Transport of multidrug resistance substrates by the Streptococcus agalactiae hemolysin transporter. J Bacteriol (2006) 1.14

Markerless multiple-gene-deletion system for Streptococcus mutans. Appl Environ Microbiol (2008) 1.14

Threonine phosphorylation prevents promoter DNA binding of the Group B Streptococcus response regulator CovR. Mol Microbiol (2009) 1.13

Bacterial phenotype variants in group B streptococcal toxic shock syndrome. Emerg Infect Dis (2009) 1.10

Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol (2011) 1.10

Long-range mapping of the Streptococcus agalactiae phylogenetic lineage restriction digest pattern type III-3 reveals clustering of virulence genes. Infect Immun (2002) 1.09

The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses. J Bacteriol (2008) 1.08

Group B Streptococcus β-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo. J Infect Dis (2014) 1.08

The pore-forming toxin β hemolysin/cytolysin triggers p38 MAPK-dependent IL-10 production in macrophages and inhibits innate immunity. PLoS Pathog (2012) 1.05

Comparative genomics analysis of Streptococcus agalactiae reveals that isolates from cultured tilapia in China are closely related to the human strain A909. BMC Genomics (2013) 1.02

Interaction of neonatal phagocytes with group B streptococcus: recognition and response. Infect Immun (2006) 0.99

A streptococcal lipid toxin induces membrane permeabilization and pyroptosis leading to fetal injury. EMBO Mol Med (2015) 0.97

Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus. J Biol Chem (2011) 0.96

Group B streptococcal haemolysin and pigment, a tale of twins. FEMS Microbiol Rev (2014) 0.95

Group B Streptococcus CovR regulation modulates host immune signalling pathways to promote vaginal colonization. Cell Microbiol (2013) 0.95

Remodeling of the Streptococcus agalactiae transcriptome in response to growth temperature. PLoS One (2008) 0.94

Genetic islands of Streptococcus agalactiae strains NEM316 and 2603VR and their presence in other Group B streptococcal strains. BMC Microbiol (2005) 0.93

Group B streptococcal beta-hemolysin/cytolysin directly impairs cardiomyocyte viability and function. PLoS One (2008) 0.91

Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis. J Infect Dis (2010) 0.89

Identification of a group B streptococcal fibronectin binding protein, SfbA, that contributes to invasion of brain endothelium and development of meningitis. Infect Immun (2014) 0.88

The Abi-domain protein Abx1 interacts with the CovS histidine kinase to control virulence gene expression in group B Streptococcus. PLoS Pathog (2013) 0.88

The classical lancefield antigen of group a Streptococcus is a virulence determinant with implications for vaccine design. Cell Host Microbe (2014) 0.87

PapR peptide maturation: role of the NprB protease in Bacillus cereus 569 PlcR/PapR global gene regulation. FEMS Immunol Med Microbiol (2009) 0.86

Molecular Characterization of Nonhemolytic and Nonpigmented Group B Streptococci Responsible for Human Invasive Infections. J Clin Microbiol (2015) 0.86

Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants. BMC Microbiol (2013) 0.86

Group B streptococcus induces trophoblast death. Microb Pathog (2008) 0.85

vanG element insertions within a conserved chromosomal site conferring vancomycin resistance to Streptococcus agalactiae and Streptococcus anginosus. MBio (2014) 0.85

β-Hemolysin/cytolysin of Group B Streptococcus enhances host inflammation but is dispensable for establishment of urinary tract infection. PLoS One (2013) 0.85

GROUP B STREPTOCOCCUS CIRCUMVENTS NEUTROPHILS AND NEUTROPHIL EXTRACELLULAR TRAPS DURING AMNIOTIC CAVITY INVASION AND PRETERM LABOR. Sci Immunol (2016) 0.85

Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization. J Infect Dis (2014) 0.84

Group B streptococcal infection of the choriodecidua induces dysfunction of the cytokeratin network in amniotic epithelium: a pathway to membrane weakening. PLoS Pathog (2014) 0.84

Induction and termination of inflammatory signaling in group B streptococcal sepsis. Immunol Rev (2008) 0.84

Group B Streptococcus interactions with human meningeal cells and astrocytes in vitro. PLoS One (2012) 0.83

Identification of three noncontiguous regions on Bacillus anthracis plasmid pXO1 that are important for its maintenance. J Bacteriol (2014) 0.82

A conserved UDP-glucose dehydrogenase encoded outside the hasABC operon contributes to capsule biogenesis in group A Streptococcus. J Bacteriol (2012) 0.82

Propionibacterium jensenii produces the polyene pigment granadaene and has hemolytic properties similar to those of Streptococcus agalactiae. Appl Environ Microbiol (2007) 0.82

Mast cell degranulation by a hemolytic lipid toxin decreases GBS colonization and infection. Sci Adv (2015) 0.81

Methylation-dependent DNA restriction in Bacillus anthracis. Gene (2011) 0.80

The role of autophagy during group B Streptococcus infection of blood-brain barrier endothelium. J Biol Chem (2014) 0.80

Granada agar sensitivity and detection of group B streptococcus. J Clin Microbiol (2003) 0.80

Host glycosaminoglycan confers susceptibility to bacterial infection in Drosophila melanogaster. Infect Immun (2008) 0.79

Adaptive response of Group B streptococcus to high glucose conditions: new insights on the CovRS regulation network. PLoS One (2013) 0.79

Role of pore-forming toxins in neonatal sepsis. Clin Dev Immunol (2013) 0.78

Inflammasome/IL-1β Responses to Streptococcal Pathogens. Front Immunol (2015) 0.78

Complete Genome Sequence of Streptococcus agalactiae CNCTC 10/84, a Hypervirulent Sequence Type 26 Strain. Genome Announc (2014) 0.78

Group B streptococcal infection and activation of human astrocytes. PLoS One (2015) 0.77

Discovery and Characterization of Human-Urine Utilization by Asymptomatic-Bacteriuria-Causing Streptococcus agalactiae. Infect Immun (2015) 0.77

Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies. Trends Microbiol (2017) 0.77

Articles by these authors

Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature (2013) 5.44

beta 0 thalassemia, a nonsense mutation in man. Proc Natl Acad Sci U S A (1979) 4.58

NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A (1996) 4.41

Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25

Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol (2001) 3.39

The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome. JAMA (1995) 3.09

Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun (1997) 2.97

Human beta-globin gene expression in transgenic mice is enhanced by a distant DNase I hypersensitive site. Proc Natl Acad Sci U S A (1989) 2.92

A sensitive new prenatal test for sickle-cell anemia. N Engl J Med (1982) 2.91

Skin microbiota: a source of disease or defence? Br J Dermatol (2008) 2.81

The nucleotide sequences of the untranslated 5' regions of human alpha- and beta-globin mRNAs. Proc Natl Acad Sci U S A (1977) 2.75

A case-control study of necrotizing fasciitis during primary varicella. Pediatrics (1999) 2.54

The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon. J Bacteriol (2000) 2.45

beta zero thalassemia in Sardinia is caused by a nonsense mutation. J Clin Invest (1981) 2.30

Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun (1996) 2.25

Evolution of a plasmid mediating resistance to multiple antimicrobial agents during a prolonged epidemic of nosocomial infections. J Infect Dis (1981) 2.13

Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci U S A (1989) 2.13

Guillain-Barré syndrome: MR imaging findings of the spine in eight patients. Radiology (1998) 2.08

Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J (1995) 2.04

New genetic techniques for group B streptococci: high-efficiency transformation, maintenance of temperature-sensitive pWV01 plasmids, and mutagenesis with Tn917. Appl Environ Microbiol (1997) 2.04

Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion. Infect Immun (1993) 2.01

UV inactivation of pathogenic and indicator microorganisms. Appl Environ Microbiol (1985) 1.91

Isolation of molecules recognized by monoclonal antibodies and antisera: the solid phase immunoisolation technique. Anal Biochem (1984) 1.91

Blue/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression. Gene (1998) 1.87

Transposable plasmid deoxyribonucleic acid sequence in Pseudomonas aeruginosa which mediates resistance to gentamicin and four other antimicrobial agents. J Bacteriol (1979) 1.85

Dissection of the enhancer activity of beta-globin 5' DNase I-hypersensitive site 2 in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.84

Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J Infect Dis (1988) 1.82

Authentic beta-globin mRNA sequences in homozygous betaO-thalassemia. Proc Natl Acad Sci U S A (1977) 1.75

A virulent nonencapsulated Haemophilus influenzae. J Infect Dis (1996) 1.73

Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol Microbiol (2000) 1.69

Occupation, smoking, and alcohol in the epidemiology of bladder cancer. Am J Public Health (1987) 1.66

Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect Immun (1994) 1.63

Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells. Infect Immun (1993) 1.63

Group B streptococci adhere to a variant of fibronectin attached to a solid phase. Mol Microbiol (1995) 1.63

Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect Immun (1992) 1.56

Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect Immun (2000) 1.52

Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition. Oncogene (2011) 1.49

Chemokine expression by intraepithelial gamma delta T cells. Implications for the recruitment of inflammatory cells to damaged epithelia. J Immunol (1996) 1.49

Novel engagement of CD14 and multiple toll-like receptors by group B streptococci. J Immunol (2001) 1.46

Initiation codon mutation as a cause of alpha thalassemia. J Biol Chem (1984) 1.45

Evolution of multiple-antibiotic-resistance plasmids mediated by transposable plasmid deoxyribonucleic acid sequences. J Bacteriol (1979) 1.44

Mesenteric and portal venous obstruction associated with primary antiphospholipid antibody syndrome. J Gastroenterol Hepatol (1997) 1.44

A model of sequential heart and composite tissue allotransplant in rats. Plast Reconstr Surg (2010) 1.42

Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology (2001) 1.39

Genetic loci of Streptococcus mitis that mediate binding to human platelets. Infect Immun (2001) 1.38

Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression. Infect Immun (1989) 1.38

Antenatal diagnosis of sickle cell anaemia by direct analysis of the sickle mutation. Lancet (1981) 1.36

Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun (1995) 1.33

Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA (2001) 1.33

An analysis of occupational risks for brain cancer. Am J Public Health (1990) 1.31

Streptococcus iniae virulence is associated with a distinct genetic profile. Infect Immun (2001) 1.30

Physical activity on the job and cancer in Missouri. Am J Public Health (1991) 1.26

Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr Res (1999) 1.26

Review of quantitative standards and guidelines for fungi in indoor air. J Air Waste Manag Assoc (1996) 1.23

Coffee-associated osteoporosis offset by daily milk consumption. The Rancho Bernardo Study. JAMA (1994) 1.23

Occupational risk factors for lung cancer among nonsmoking women: a case-control study in Missouri (United States). Cancer Causes Control (1993) 1.23

Regulation of purine biosynthesis by a eukaryotic-type kinase in Streptococcus agalactiae. Mol Microbiol (2005) 1.22

Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells In vitro. Infect Immun (1998) 1.19

Hepatic cavernous hemangioma: sonographic patterns and speed of contrast enhancement on multiphase dynamic MR imaging. AJR Am J Roentgenol (1998) 1.18

Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci. J Pediatr (1993) 1.18

Evolution of antimicrobial resistance and nosocomial infection. Lessons from the Vanderbilt experience. Am J Med (1981) 1.18

A study of the accuracy of cancer risk factor information reported to a central registry compared with that obtained by interview. Am J Epidemiol (1989) 1.18

Epidemiology and prevention of lung cancer in nonsmokers. Epidemiol Rev (1998) 1.13

Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Pediatr Infect Dis J (1996) 1.13

The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats. J Infect Dis (1992) 1.13

Suppression of the nonsense mutation in homozygous beta 0 thalassaemia. Nature (1979) 1.11

Interaction of Ba2+ with the pores of the cloned inward rectifier K+ channels Kir2.1 expressed in Xenopus oocytes. Biophys J (1998) 1.11

Flavimonas oryzihabitans bacteremia: clinical features and microbiological characteristics of isolates. Clin Infect Dis (1997) 1.11

Characterization of cpsF and its product CMP-N-acetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli. Mol Microbiol (1996) 1.10

Cancer risks among Missouri farmers. Cancer (1989) 1.09

A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections. J Infect Dis (1997) 1.09

A change in the subcellular distribution of noradrenaline in the rat isolated vas deferens effected by nerve stimulation. Br J Pharmacol Chemother (1965) 1.08

Huntingtin interacting protein 1 Is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors. Mol Cell Biol (2001) 1.07

Occupational risk of colon cancer. An analysis by anatomic subsite. Am J Epidemiol (1989) 1.07

Cigarette smoking and risk of adult leukemia. Am J Epidemiol (1991) 1.07

The nucleotide sequence of the 5' untranslated region of human gamma-globin mRNA. Nucleic Acids Res (1978) 1.06

NeuD plays a role in the synthesis of sialic acid in Escherichia coli K1. FEMS Microbiol Lett (2000) 1.06

Use of a dental amalgamator to extract RNA from the gram-positive bacterium Streptococcus agalactiae. Biotechniques (1997) 1.06

Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J Bacteriol (2005) 1.06

Severity of group B streptococcal arthritis is correlated with beta-hemolysin expression. J Infect Dis (2000) 1.05

Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology (1992) 1.05

Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun (2000) 1.03

Family history of cancer and risk of lung cancer in lifetime non-smokers and long-term ex-smokers. Int J Epidemiol (1997) 1.02

DNA repair signature is associated with anthracycline response in triple negative breast cancer patients. Breast Cancer Res Treat (2010) 1.02

Analysis of restriction fragment length polymorphisms of the insertion sequence IS1381 in group B Streptococci. J Infect Dis (2000) 1.01

Unusual abnormal X chromosome in hyperthyroidism and Turner's syndrome. N Y State J Med (1973) 1.01

Cloning and expression in Escherichia coli of a gene encoding nonenzymatic chloramphenicol resistance from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 1.01

Study of lung cancer histologic types, occupation, and smoking in Missouri. Am J Ind Med (1989) 1.01

Detection of an advanced glycosylation product bound to protein in situ. J Biol Chem (1985) 1.00

K+ binding sites and interactions between permeating K+ ions at the external pore mouth of an inward rectifier K+ channel (Kir2.1). J Biol Chem (1999) 0.99

Differentiation of cultured keratinocytes promotes the adherence of Streptococcus pyogenes. J Clin Invest (1998) 0.99

Effect of single or repeated formaldehyde exposure on minute volume of B6C3F1 mice and F-344 rats. Toxicol Appl Pharmacol (1981) 0.99

Studies on the interactions of guanethidine and bretylium with noradrenaline stores. Br J Pharmacol Chemother (1967) 0.98

Post-operative thrombotic thrombocytopenic purpura: a review. Int J Clin Pract (2004) 0.97

Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis. Infect Immun (1987) 0.97

Acute bullous dermatosis and onycholysis due to high-dose methotrexate and leucovorin calcium. Arch Dermatol (1987) 0.97

Assigning the polymorphic human insulin gene to the short arm of chromosome 11 by chromosome sorting. Hum Genet (1982) 0.96